REGULATORY DOSE

India makes a long overdue move to ensure better drug safety

The health ministry has made bioequivalence studies compulsory for some generic drugs.

In a long overdue move the Ministry of Health and Family Welfare has finally amended the law to make bioequivalence studies compulsory for certain classes of generic drugs manufactured in India. The government first advertised the draft amendments in early February for public comment and then formally amended the Drugs & Cosmetics Rules, 2017 through a notification on April 3 to incorporate the change.

Bioequivalence studies are studies conducted to establish that two medicines, normally the original patented drug and a generic version, have the same biological equivalence – that is, that they work the same way, to the same extent and for the same purpose. The new law required bioequivalence studies to be performed on drugs with low solubility. Although it is preferable to have a system of by which bioequivalence should be established for all drugs, this requirement is often waived for drugs that are highly water soluble as they are likely to with high solubility are considered to be more easily absorbed in the body.

In order to understand the significance of these amendments it is necessary to understand the history of modern drug regulation, especially in the context of generic medicines. The modern drug regulatory framework can be traced to the sixties when the United States amended its law to require drug manufacturers to demonstrate proof of efficacy of their new drugs. Until then the main policy objective of regulation was to ensure quality of drugs per the manufacturer’s specifications. Proof of efficacy required the conduct of extensive clinical trials, often requiring thousands of patients and the cost these days runs into hundreds of millions of dollars. The cost of clinical trials created a new entry barrier for competitors to enter the market after the patents over the original drug expired.

The United States Congress responded by enacting the Hatch Waxman Act in 1984 creating a new regulatory pathway that would enable competitors to introduce generic versions of the proprietary drugs without the requirement of repeating expensive clinical trials. The one mandatory requirement to gain approval for a generic under this new regulatory pathway was the conduct of bioequivalence studies. These studies are aimed at studying whether the generic drug behaves in the same manner as the innovator drug – that is, whether it dissolves at the same rate into the bloodstream thereby demonstrating similar therapeutic properties as the innovator.

Lower costs of generics

These studies are usually conducted on a much smaller group of healthy volunteers than is the case with clinical studies which are conducted on patients suffering from the disease in question. As a result, the cost of a bioequivalence study is only a small fraction of conducting full-fledged clinical trials. This practice of approving generics based on bioequivalence studies is one of the reasons that generic drugs are much more affordable than patented versions of the drugs.

The legal requirement in India under the Drugs & Cosmetics Rules, 1945 for conducting bioequivalence studies has, so far, been limited to only those generics that are approved by the Drug Controller General of India within the first four years of the innovator drug being approved in India. For example, if Pfizer has a new drug approved in 2012 after submitting clinical trial data, manufacturers of all generics versions for that drug to be launched in the market between 2012 and 2016 must seek permission from the Drug Controller General of India and submit data on bioequivalence studies in cases where there is no valid patent. For those generics entering the market after the four year process only require permission from state licensing authorities, who are not required to demand data on bioequivalence studies under the Drugs & Cosmetics Rules, 1945.

This distinction between generics approved within the first four years and those approved from the fifth year, has no basis in science and has without doubt jeopardised public health because state licensing authorities were in effect approving generics with absolutely no data on their performance. As a result doctors have been prescribing generics without having any data on the performance of these drugs. As a result most domestic manufacturers catering for the Indian market would wait till the fifth year and get approval to manufacture and sell generics without conducting bioequivalence studies.

Those manufacturers exporting to the US and the European Union would still be required to conduct these studies in order to gain marketing approval for those jurisdictions. In fact, even these companies have faced serious allegation of fraud regarding the manner in which these bioequivalence studies are conducted as exposed in the Ranbaxy scandal and more recently the GVK Bio scandal.

The Indian debate

In 2013, an expert committee headed by Dr Ranjit Roy Choudhary had recommended making bioequivalence studies compulsory for all generics irrespective of when they were approved. Surprisingly when this recommendation was discussed by the Drug Consultative Committee, which has all state drug controllers and the Drug Controller General of India as members, the recommendation was rejected not on the basis of science but on commercial feasibility. At its 47th meeting held in July, 2014 the Drug Consultative Committee stated the following while rejecting the Choudhary Committee recommendation:

“The recommendations of the Prof Ranjit Roy Chaudhury Committee in respect of Bioavailability or Bioequivalence (BA / BE) studies conducted in India were deliberated in detail. The members were of the view that BA / BE studies in respect of drugs manufactured in the country shall be insisted whenever there are issues relating to patient safety and variable bioavailability. As the infrastructure for conduct of such studies is not uniformly available in the country it cannot be implemented as a rule.”

The rejection of this view that bioequivalence studies should be undertaken on case by case basis was yet another egregious example of how decisions related to patient safety are guided by the commercial interests of the Indian pharmaceutical industry rather than public health. Even more egregious perhaps was the Drug Consultative Committee’s claim that India lacked the infrastructure to conduct such studies. At that point in time India had one of the largest clinical research establishments in the world.

Last year, Ranbaxy whistleblower Dinesh Thakur had filed two PILs before the Supreme Court seeking, amongst other prayers, that the government make bioequivalence studies mandatory for the approval of all generics (full disclosure: I was his lawyer in the case). A bench headed by the then Chief Justice TS Thakur dismissed the PILs as raising issues of mere “academic interest”. The same judge however did admit a PIL on banning sardar jokes.

Thereafter, Thakur and I prepared a comprehensive report and submitted the same to the Ministry of Health where we specifically highlighted the issue of bioequivalence studies.

It is not clear what influenced the government to change its mind and make bioequivalence studies compulsory but the health ministry certainly deserves credit for making the decision.

The challenge for the future will be to ensure that clinical research organisations that conduct bioequivalence studies do not commit fraud. This is a daunting task given the list of organisations that have been caught red-handed by foreign regulators.

The writer is a research associate at the School of Law, Singapore Management University.

We welcome your comments at letters@scroll.in.
Sponsored Content BY 

Top picks, best deals and all that you need to know for the Amazon Great Indian Festival

We’ve done the hard work so you can get right to what you want amongst the 40,000+ offers across 4 days.

The Great Indian Festival (21st-24th September) by Amazon is back and it’s more tempting than ever. This edition will cater to everyone, with offers on a range of products from electronics, home appliances, apparel for men and women, personal care, toys, pet products, gourmet foods, gardening accessories and more. With such overwhelming choice of products and a dozen types of offers, it’s not the easiest to find the best deals in time to buy before your find gets sold out. You need a strategy to make sure you avail the best deals. Here’s your guide on how to make the most out of the Great Indian Festival:

Make use of the Amazon trio – Amazon Prime, Amazon Pay and Amazon app

Though the festival officially starts on 21st, Amazon Prime members will have early access starting at 12 noon on 20th September itself, enabling them to grab the best deals first. Sign up for an Amazon Prime account to not miss out on exclusive deals and products. Throughout the festival, Prime members will 30-minute early access to top deals before non-Prime members. At Rs 499/- a year, the Prime membership also brings unlimited Amazon Prime video streaming and quick delivery benefits.

Load your Amazon pay wallet; there’s assured 10% cashback (up to Rs 500). Amazon will also offer incremental cashbacks over and above bank cashbacks on select brands as a part of its Amazon Pay Offers. Shopping from the app would bring to you a whole world of benefits not available to non-app shoppers. App-only deals include flat Rs 1,250 off on hotels on shopping for more than Rs 500, and flat Rs 1,000 off on flights on a roundtrip booking of Rs 5,000 booking from Yatra. Ten lucky shoppers can also win one year of free travel worth Rs 1.5 lakhs.

Plan your shopping

The Great Indian Sale has a wide range of products, offers, flash sales and lightning deals. To make sure you don’t miss out on the best deals, or lose your mind, plan first. Make a list of things you really need or have been putting off buying. If you plan to buy electronics or appliances, do your research on the specs and shortlist the models or features you prefer. Even better, add them to your wishlist so you’re better able to track your preferred products.

Track the deals

There will be lightning deals and golden hour deals throughout the festival period. Keep track to avail the best of them. Golden-hour deals will be active on the Amazon app from 9.00pm-12.00am, while Prime users will have access to exclusive lightning deals. For example, Prime-only flash sales for Redmi 4 will start at 2.00pm and Redmi 4A at 6.00pm on 20th, while Nokia 6 will be available at Rs 1,000 off. There will be BOGO Offers (Buy One Get One free) and Bundle Offers (helping customers convert their TVs to Smart TVs at a fraction of the cost by using Fire TV Stick). Expect exclusive product launches from brands like Xiaomi (Mi Band 2 HRX 32 GB), HP (HP Sprocket Printer) and other launches from Samsung and Apple. The Half-Price Electronics Store (minimum 50% off) and stores offering minimum Rs 15,000 off will allow deal seekers to discover the top discounts.

Big discounts and top picks

The Great Indian Festival is especially a bonanza for those looking to buy electronics and home appliances. Consumers can enjoy a minimum of 25% off on washing machines, 20% off on refrigerators and 20% off on microwaves, besides deals on other appliances. Expect up to 40% off on TVs, along with No-Cost EMI and up to Rs 20,000 off on exchange.

Home Appliances

Our top picks for washing machines are Haier 5.8 Kg Fully Automatic Top Loading at 32% off, and Bosch Fully Automatic Front Loading 6 Kg and 7 Kg, both available at 27% discount. Morphy Richards 20 L Microwave Oven will be available at a discount of 38%.

Our favorite pick on refrigerators is the large-sized Samsung 545 L at 26% off so you can save Rs 22,710.

There are big savings to be made on UV water purifiers as well (up to 35% off), while several 5-star ACs from big brands will be available at greater than 30% discount. Our top pick is the Carrier 1.5 Ton 5-star split AC at 32% off.

Personal Electronics

There’s good news for Apple fans. The Apple MacBook Air 13.3-inch Laptop 2017 will be available at Rs 55,990, while the iPad will be available at 20% off. Laptops from Lenovo, Dell and HP will be available in the discount range of 20% to 26%. Top deals are Lenovo Tab3 and Yoga Tab at 41% to 38% off. Apple fans wishing to upgrade to the latest in wearable technology can enjoy Rs 8,000 off on the Apple Watch series 2 smartwatch.

If you’re looking for mobile phones, our top deal pick is the LG V20 at Rs 24,999, more than Rs 5000 off from its pre-sale price.

Power banks always come in handy. Check out the Lenovo 13000 mAh power bank at 30% off.

Home printers are a good investment for frequent flyers and those with kids at home. The discounted prices of home printers at the festival means you will never worry about boarding passes and ID documents again. The HP Deskjet basic printer will be available for Rs 1,579 at 40% off and multi-function (printer/ scanner/ Wi-Fi enabled) printers from HP Deskjet and Canon will also available at 33% off.

The sale is a great time to buy Amazon’s native products. Kindle E-readers and Fire TV Stick will be on sale with offers worth Rs 5,000 and Rs 1,000 respectively.

The Amazon Fire Stick
The Amazon Fire Stick

For those of you who have a bottomless collection of movies, music and photos, there is up to 60% off on hard drives and other storage devices. Our top picks are Rs 15,000 and Rs 12,000 off on Seagate Slim 5TB and 4TB hard drives respectively, available from 8.00am to 4.00pm on 21st September.

The sale will see great discounts of up to 60% off on headphones and speakers from the top brands. The 40% off on Bose QC 25 Headphones is our favourite. Top deals are on Logitech speakers with Logitech Z506 Surround Sound 5.1 multimedia Speakers at 60% off and Logitech X300 Bluetooth Speaker at 58% off!

Other noteworthy deals

Cameras (up to 55% off) and camera accessories such as tripods, flash lights etc. are available at a good discount. Home surveillance cameras too will be cheaper. These include bullet cameras, dome cameras, simulated cameras, spy cameras and trail and game cameras.

For home medical supplies and equipment, keep an eye on the grooming and personal care section. Weighing scales, blood pressure monitors, glucometers, body fat monitors etc. will be available at a cheaper price.

The sale is also a good time to invest in home and kitchen supplies. Mixer-grinders and juicers could see lightning deals. Don’t ignore essentials like floor mops with wheels, rotating mop replacements, utensils, crockery etc. Tupperware sets, for example, will be more affordable. There are attractive discounts on bags, especially laptop bags, backpacks, diaper bags and luggage carriers.

Interesting finds

While Amazon is extremely convenient for need-based shopping and daily essentials, it is also full of hidden treasures. During the festival, you can find deals on telescopes, polaroid cameras, smoothie makers, gym equipment, gaming consoles and more. So you’ll be able to allow yourself some indulgences!

Small shopping

If you have children, the festival is good time to stock up on gifts for Diwali, Christmas, return gifts etc. On offer are gaming gadgets such as Xbox, dough sets, Touching Tom Cat, Barbies, classic board games such as Life and more. There are also some products that you don’t really need, but kind of do too, such as smartphone and tablet holders, magnetic car mounts for smartphones and mobile charging station wall stands. If you’re looking for enhanced functionality in daily life, do take a look at the Amazon Basics page. On it you’ll find USB cables, kitchen shears, HDMI cables, notebooks, travel cases and other useful things you don’t realise you need.

Check-out process and payment options

Amazon is also offering an entire ecosystem to make shopping more convenient and hassle-free. For the festival duration, Amazon is offering No-Cost EMIs (zero interest EMIs) on consumer durables, appliances and smartphones, plus exchange schemes and easy installation services in 65 cities. HDFC card holders can avail additional 10% cashback on HDFC credit and debit cards. Customers will also get to “Buy Now and Pay in 2018” with HDFC Credit Cards, as the bank offers a 3 Month EMI Holiday during the days of the sale. Use Amazon Pay balance for fast and easy checkouts, quicker refunds and a secured shopping experience.

Sales are fun and with The Great Indian Festival offering big deals on big brands, it definitely calls for at least window shopping. There’s so much more than the above categories, like minimum 50% off on American Tourister luggage! To start the treasure hunt, click here.

This article was produced by the Scroll marketing team on behalf of Amazon.in and not by the Scroll editorial team.